维普中文期刊产品整合服务
33篇 您的检索式:作者名="Loiarro"
    题名 作者 年代 出处 被引量
1Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases 显示文摘Loiarro M Gallo G Desantis R 2009J Biol Chem2009,284,28:1
2Targeting the Toll-like receptor/interleukin 1receptor pathway in human diseases:rational design of MyD88inhibitors显示文摘LOIARRO M RUGGIERO V SETTE C 2013Clin Lymphoma Myeloma Leuk2013,13,:1
3Peptide-mediated inter-ference of TIR domain dimerization in MyD88 inhibits in-terleukin-1-dependent activation of NF-κB显示文摘Loiarro M Sette C Gallo G 0,,16:1
4Pivotal Advance:inhibition of MyD88 dimerization and recruitment of IRAK1and IRAK4 by a novel eptidomimetic compound显示文摘Loiarro M Capolunghi F Fanto N 0,,04:1
5Identification of critical resi- dues of the MyD88 death domain involved in the recruitment of downstream kinases显示文摘Loiarro M Gallo G Fanto N 2009J Biol Chem2009,284,28:1
6Mutational analysis iden- tifies residues crucial for homodimerization of myeloid difterentia- tion factor 88( MyD88 ) and for its function in immune cells显示文摘Loiarro M Volpe E Ruggiero V 2013J Biol Chem2013,288,30:1
7Phosphorylation of eIF4E by MNKs supports protein synthesis,cell cycle progression and proliferation in prostate cancer cells显示文摘BIANCHINI A LOIARRO M BIELLI P 2008Carcinogenesis2008,29,12:1
8Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases 显示文摘Loiarro M Gallo G 2009J Biol Chem2009,284,28:1
9Pivotal Advance:Inhibition of MyD88 dimerization and recruitment ofIRAK1 and IRAK4 by a novel peptidomimetic compound显示文摘Loiarro M Capolunghi F Fanto N 2007J Leukoc Biol2007,82,4:1
10Pivotal advance: inhi- bition of MyD88 dimerization and recruitment of IRAK1 and I- RAK4 by a novel peptidomimetic compound 显示文摘Loiarro M Capolunghi F Fanto N 2007J Leukoc Biol2007,82,4:1
11Identification of criti- cal residues of the MyD88 death domain involved in the re- cruitment of downstream kinases显示文摘Loiarro M Gallo G Fantb N 2009J Biol Chem2009,284,28:1
12Targeting the Toll-like receptor/ interleukin 1 receptor pathway in human diseases : rational design of MyD88 inhibitors显示文摘Loiarro M Ruggiero V Sette C 2013Clin Lymphoma Myeloma Leuk2013,13,2:1
13Identification of critical residues of the MyD88 death domain involved in therecruitment of downstream kinases显示文摘Loiarro M Gallo G Fant N 2009J Biol Chem2009,284,28:1
14Phosphorylation of eIF4E by MNKs supports protein synthesis,cell cycle progression and proliferation in prostate cancer cells显示文摘Bianchini A Loiarro M Bielli P 2008Carcinogenesis2008,29,12:1
15Pivotal advance:Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound显示文摘Loiarro M Capolunghi F Fanto N 2007Leuko Biol2007,82,4:1
16Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-l-dependent activation of NF-κB显示文摘Loiarro M Sette C Gallo G 0,,16:1
17Pivotal Advance:inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel eptidomimetic compound显示文摘Loiarro M Capolunghi F Fanto N 0,,04:1
18Identification of critical residues of the MYD88 death domain involved in the recruitment of downstream kinases显示文摘Loiarro M Gatlo G Fanto N 0,,41:1
19Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases显示文摘LOIARRO M GALLO G DE SANTIS R 2009J Biol Chem2009,284,28:1
20Pivotal advance : inhibi- tion of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound 显示文摘Loiarro M Capolunghi F Fanto N 2007J Leukoc Biol2007,82,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费